054 - "EUDAMED" with Richard Houlihan

Let's Combinate · 12 Oct 2022 · 28m

What this episode covers

Richard Houlihan, CEO of Eirmed, discusses the history, structure, and compliance requirements of EUDAMED, the European Commission's medical device database. He details the system's six modules, highlighting the complexity of the clinical investigations module and the shift from private competent authority access to public transparency for device data. Houlihan explains the legal obligations for economic operators, including manufacturers, authorized representatives, and importers, emphasizing that EUDAMED is a mandatory cost of doing business in Europe with strict data validation rules.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 1h 02m

    #339: UDI and the State of EUDAMED

    Richard Houlihan, founder of EirMed and former head of the European Commission's IT team for EUDAMED, explains the history, delays, and technical complexities of the European Database for Medical Devices. He details the shift from legacy systems to the new UDI Device Module, highlighting the massive data collation efforts required for compliance with the Medical Device Regulation (MDR). Houlihan warns that while the database is delayed until Q2 2025, companies must start preparing now to avoid legal sales bans and vigilance reporting failures.

  • Global Medical Device Podcast · 30m

    [LIVE] How EU MDR Changes are Impacting the Medical Device Ecosystem

    Jon Speer hosts a live discussion with Evangeline Loh, Vice President of Regulatory Affairs at Emergo Group, regarding the impact of the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) on the medical device ecosystem. They detail critical regulatory shifts, including the delay of the EUDAMED database to 2022, the up-classification of self-certified Class I devices under Corrigendum 2, and the severe bottleneck caused by having only 11 designated Notified Bodies. The conversation highlights the strategic advantage of securing legacy MDD certification before May 2020 to avoid MDR compliance until 2024, while also addressing the regulatory duplication and market access challenges introduced by Brexit.

  • Global Medical Device Podcast · 50m

    Bridging the Gap between Medical Devices and Clinical Data

    Adam Steadman, Chief Commercial Officer for SMART-TRIAL, explains how Electronic Data Capture (EDC) software bridges the gap between medical device development and clinical data requirements, particularly under the EU MDR. He details the necessity of collecting five distinct data streams—algorithm, proof of concept, regulatory, payor, and physician adoption data—to ensure market success and reimbursement. Steadman highlights that the EU MDR has forced manufacturers to prove ongoing effectiveness, leading to SKU rationalization and a shift in clinical trial strategies from Europe to the US. He warns against taking shortcuts in clinical trials, such as conducting 'first-in-human' studies without proper risk assessment, and emphasizes adherence to ISO 14155 and ISO 20916 standards for patient safety and regulatory compliance.

  • Global Medical Device Podcast · 34m

    Explaining the Role of Importer under EU MDR

    René Van De Zande, partner at MedEnvoy Global and former CEO of EMERGO by UL, explains the critical role of importers under the EU Medical Device Regulation (EU MDR). He details how importers and distributors share overlapping obligations under Articles 13 and 14, requiring robust quality management systems and due diligence to ensure device compliance, traceability, and proper labeling. Van De Zande highlights the operational challenges of managing multiple distributors as de facto importers and the necessity of independent importer services to maintain supply chain control. The discussion also covers regulatory nuances in the UK post-Brexit and Switzerland following the loss of the Mutual Recognition Agreement.

  • Global Medical Device Podcast · 45m

    UDI and the Current State of Global Implementation

    Gary Saner, Senior Manager of Information Solutions at Reed Tech, discusses the complexities of Unique Device Identification (UDI) implementation in the US and EU. He details the FDA's Class I UDI deadlines, the four quadrants of compliance, and the data challenges of submitting to GUDID. Saner contrasts this with the EU's MDR/IVDR overhaul, explaining the EUDAMED database, the 'Basic UDI-DI' concept, and the lack of global harmonization.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.